French Defence Health Service
Quick facts
Phase 3 pipeline
- French Lyophilized Plasma · Hematology / Hemostasis / Critical Care
French Lyophilized Plasma replaces clotting factors and other plasma proteins to restore hemostatic function in patients with coagulopathy or massive hemorrhage.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about French Defence Health Service
What is French Defence Health Service's pipeline?
French Defence Health Service has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include French Lyophilized Plasma.
Related
- Sector hub: All tracked pharma companies